|
Volumn 26, Issue SUPPL. 2, 2006, Pages 1-2
|
Management of chronic hepatitis B: An evolving issue
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
ANTIVIRUS AGENT;
CLEVUDINE;
DNA POLYMERASE;
ENTECAVIR;
PEGINTERFERON ALPHA2A;
TELBIVUDINE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ASIA;
CHILD CARE;
CHINA;
COMORBIDITY;
CONSENSUS DEVELOPMENT;
CORRELATION ANALYSIS;
DISEASE COURSE;
DISEASE TRANSMISSION;
DRUG RESEARCH;
EDITORIAL;
ENDEMIC DISEASE;
EPIDEMIOLOGICAL DATA;
GENE MUTATION;
HEALTH CARE AVAILABILITY;
HEALTH CARE COST;
HEALTH CARE FACILITY;
HEALTH CARE ORGANIZATION;
HEALTH CARE PERSONNEL;
HEALTH CARE QUALITY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNE DEFICIENCY;
INCIDENCE;
INDIA;
INTRAVENOUS DRUG ABUSE;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MEDICAL EXPERT;
MEDICAL INFORMATION;
MEDICAL SPECIALIST;
PACIFIC ISLANDS;
PATIENT CARE;
PRACTICE GUIDELINE;
PREGNANCY;
PREVALENCE;
PRIMARY MEDICAL CARE;
RISK ASSESSMENT;
SEXUAL BEHAVIOR;
SOCIOECONOMICS;
VIROLOGY;
VIRUS LOAD;
VIRUS TRANSMISSION;
|
EID: 33750726385
PISSN: 14783223
EISSN: 14783231
Source Type: Journal
DOI: 10.1111/j.1478-3231.2006.01369.x Document Type: Editorial |
Times cited : (3)
|
References (4)
|